Dmitriy Pereyaslov

2.4k total citations
19 papers, 725 citations indexed

About

Dmitriy Pereyaslov is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Dmitriy Pereyaslov has authored 19 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Agronomy and Crop Science. Recurrent topics in Dmitriy Pereyaslov's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (13 papers) and Animal Disease Management and Epidemiology (5 papers). Dmitriy Pereyaslov is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (13 papers) and Animal Disease Management and Epidemiology (5 papers). Dmitriy Pereyaslov collaborates with scholars based in Denmark, Netherlands and Sweden. Dmitriy Pereyaslov's co-authors include Wenqing Zhang, Angie Lackenby, Adam Meijer, Eeva Broberg, Rod S. Daniels, Emi Takashita, Dayan Wang, Sebastian Maurer‐Stroh, Larisa V. Gubareva and Jing‐Kai Huang and has published in prestigious journals such as Antiviral Research, BMC Infectious Diseases and Eurosurveillance.

In The Last Decade

Dmitriy Pereyaslov

19 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitriy Pereyaslov Denmark 13 533 267 138 77 60 19 725
Xavier Bouhy Canada 13 541 1.0× 119 0.4× 138 1.0× 103 1.3× 41 0.7× 17 591
J. Ives United Kingdom 9 1.0k 1.9× 211 0.8× 178 1.3× 76 1.0× 24 0.4× 10 1.1k
Janice Lo China 14 548 1.0× 223 0.8× 135 1.0× 86 1.1× 130 2.2× 26 740
Manohar Lal Choudhary India 13 359 0.7× 255 1.0× 128 0.9× 46 0.6× 21 0.3× 24 579
Naomi Komadina Australia 20 964 1.8× 236 0.9× 222 1.6× 143 1.9× 52 0.9× 28 1.0k
Hitoshi Oshitani Japan 12 527 1.0× 200 0.7× 132 1.0× 60 0.8× 37 0.6× 29 655
Hatairat Lerdsamran Thailand 10 365 0.7× 200 0.7× 69 0.5× 68 0.9× 23 0.4× 33 465
Concetta Fabiani Italy 12 424 0.8× 292 1.1× 62 0.4× 53 0.7× 22 0.4× 18 609
Hideka Miura Japan 11 294 0.6× 266 1.0× 121 0.9× 117 1.5× 59 1.0× 22 597
Chee Keng Mok Singapore 12 294 0.6× 222 0.8× 139 1.0× 55 0.7× 22 0.4× 29 511

Countries citing papers authored by Dmitriy Pereyaslov

Since Specialization
Citations

This map shows the geographic impact of Dmitriy Pereyaslov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitriy Pereyaslov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitriy Pereyaslov more than expected).

Fields of papers citing papers by Dmitriy Pereyaslov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitriy Pereyaslov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitriy Pereyaslov. The network helps show where Dmitriy Pereyaslov may publish in the future.

Co-authorship network of co-authors of Dmitriy Pereyaslov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitriy Pereyaslov. A scholar is included among the top collaborators of Dmitriy Pereyaslov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitriy Pereyaslov. Dmitriy Pereyaslov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yamaji, Reina, Wenqing Zhang, Akiko Kamata, et al.. (2024). Pandemic risk characterisation of zoonotic influenza A viruses using the Tool for Influenza Pandemic Risk Assessment (TIPRA). The Lancet Microbe. 6(3). 100973–100973. 6 indexed citations
2.
Akande, Oluwatosin Wuraola, Babak Afrough, Jane Cunningham, et al.. (2024). Investing in health preparedness, response and resilience: a genomics costing tool focused on next generation sequencing. Frontiers in Public Health. 12. 1404243–1404243. 3 indexed citations
3.
Cozza, Vanessa, et al.. (2021). Leveraging Global Influenza Surveillance and Response System for the COVID-19 Pandemic Response and Beyond. China CDC Weekly. 3(44). 937–940. 11 indexed citations
4.
Mook, Piers, T J Meerhoff, Sonja J. Olsen, et al.. (2020). Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018. Influenza and Other Respiratory Viruses. 14(2). 150–161. 12 indexed citations
5.
Takashita, Emi, Rod S. Daniels, Seiichiro Fujisaki, et al.. (2020). Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018. Antiviral Research. 175. 104718–104718. 86 indexed citations
6.
Alm, Erik, Eeva Broberg, Thomas R. Connor, et al.. (2020). Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Eurosurveillance. 25(32). 131 indexed citations
7.
Melidou, Angeliki, Dmitriy Pereyaslov, Olav Hungnes, et al.. (2020). Virological surveillance of influenza viruses in the WHO European Region in 2019/20 – impact of the COVID-19 pandemic. Eurosurveillance. 25(46). 20 indexed citations
8.
Segaloff, Hannah E., Angeliki Melidou, Cornelia Adlhoch, et al.. (2019). Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019. Eurosurveillance. 24(9). 15 indexed citations
9.
Lackenby, Angie, Terry G. Besselaar, Rod S. Daniels, et al.. (2018). Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017. Antiviral Research. 157. 38–46. 100 indexed citations
10.
Gubareva, Larisa V., Terry G. Besselaar, Rod S. Daniels, et al.. (2017). Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016. Antiviral Research. 146. 12–20. 85 indexed citations
11.
Meerhoff, T J, et al.. (2016). The potential risks and impact of the start of the 2015–2016 influenza season in the WHO European Region: a rapid risk assessment. Influenza and Other Respiratory Viruses. 10(4). 236–246. 13 indexed citations
12.
Takashita, Emi, Adam Meijer, Angie Lackenby, et al.. (2015). Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014. Antiviral Research. 117. 27–38. 124 indexed citations
13.
Broberg, Eeva, R Snacken, Cornelia Adlhoch, et al.. (2015). Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Eurosurveillance. 20(4). 53 indexed citations
14.
Pereyaslov, Dmitriy, et al.. (2015). Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System. Influenza and Other Respiratory Viruses. 10(2). 68–75. 6 indexed citations
15.
Broberg, Eeva, Dmitriy Pereyaslov, Marc Struelens, et al.. (2014). Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013. Eurosurveillance. 19(4). 4 indexed citations
16.
Pereyaslov, Dmitriy, Paul L. Rosin, Daniel Palm, et al.. (2014). Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013. Eurosurveillance. 19(40). 20923–20923. 18 indexed citations
17.
Thompson, Catherine, Angie Lackenby, R. S. Daniels, et al.. (2012). Evaluation of influenza virus antiviral susceptibility testing in Europe: Results from the first external quality assessment exercise. Journal of Clinical Virology. 56(3). 296–302. 6 indexed citations
18.
Paget, W J, Pernille Jorgensen, Caroline S. Brown, et al.. (2012). The community impact of the 2009 influenza pandemic in the WHO European Region: a comparison with historical seasonal data from 28 countries. BMC Infectious Diseases. 12(1). 36–36. 17 indexed citations
19.
Palm, Daniel, Dmitriy Pereyaslov, Eeva Broberg, et al.. (2012). Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Eurosurveillance. 17(49). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Bouhy Breakdown of academic impact, for papers by J. Ives Breakdown of academic impact, for papers by Janice Lo Breakdown of academic impact, for papers by Manohar Lal Choudhary Breakdown of academic impact, for papers by Naomi Komadina Breakdown of academic impact, for papers by Hitoshi Oshitani Breakdown of academic impact, for papers by Hatairat Lerdsamran Breakdown of academic impact, for papers by Concetta Fabiani Breakdown of academic impact, for papers by Hideka Miura Breakdown of academic impact, for papers by Chee Keng Mok
Rankless by CCL
2026